JP2012511558A5 - - Google Patents

Download PDF

Info

Publication number
JP2012511558A5
JP2012511558A5 JP2011540193A JP2011540193A JP2012511558A5 JP 2012511558 A5 JP2012511558 A5 JP 2012511558A5 JP 2011540193 A JP2011540193 A JP 2011540193A JP 2011540193 A JP2011540193 A JP 2011540193A JP 2012511558 A5 JP2012511558 A5 JP 2012511558A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
compound
halogen
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011540193A
Other languages
English (en)
Other versions
JP2012511558A (ja
JP5732400B2 (ja
Filing date
Publication date
Priority claimed from GBGB0822486.7A external-priority patent/GB0822486D0/en
Application filed filed Critical
Publication of JP2012511558A publication Critical patent/JP2012511558A/ja
Publication of JP2012511558A5 publication Critical patent/JP2012511558A5/ja
Application granted granted Critical
Publication of JP5732400B2 publication Critical patent/JP5732400B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (7)

  1. 一般式(III)
    Figure 2012511558
    (式中、R 、R 10 、R 11 、R 12 およびR 13 は、それぞれ独立して、水素、ハロゲン、置換または非置換アルキル、置換または非置換アルコキシ、置換または非置換アミン、置換または非置換アミド、置換または非置換アリール、および置換または非置換ヘテロアリールから成る群より選択される。)
    の化合物、またはその塩
  2. およびR13の少なくとも1つがハロゲンまたは置換もしくは非置換C1−4アルキルである請求項1に記載の化合物。
  3. 10およびR12の少なくとも1つが、水素、ハロゲンおよび置換または非置換アルキルから成る群より選択される請求項1または2に記載の化合物。
  4. 11が水素、ハロゲン、置換または非置換アルキル、置換または非置換アルコキシ、および置換または非置換フェニルから成る群より選択される請求項1〜3のいずれか1項に記載の化合物。
  5. 式:
    Figure 2012511558
    化合物、またはその塩
  6. 治療的有効量の請求項1〜5のいずれか1項に記載の化合物またはその塩と、製薬学的に許容可能なビヒクルとを含む医薬組成物。
  7. 疼痛の治療に使用するための、請求項1〜5のいずれか1項に記載の化合物もしくはその塩、または請求項6に記載の医薬組成物
JP2011540193A 2008-12-10 2009-12-09 疼痛の治療で使用するための化合物 Active JP5732400B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0822486.7A GB0822486D0 (en) 2008-12-10 2008-12-10 Compounds for use in the treatment of pain
GB0822486.7 2008-12-10
PCT/GB2009/002850 WO2010067069A1 (en) 2008-12-10 2009-12-09 Compounds for use in the treatment of pain

Publications (3)

Publication Number Publication Date
JP2012511558A JP2012511558A (ja) 2012-05-24
JP2012511558A5 true JP2012511558A5 (ja) 2013-01-31
JP5732400B2 JP5732400B2 (ja) 2015-06-10

Family

ID=40289770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011540193A Active JP5732400B2 (ja) 2008-12-10 2009-12-09 疼痛の治療で使用するための化合物

Country Status (8)

Country Link
US (1) US8507724B2 (ja)
EP (1) EP2373605B1 (ja)
JP (1) JP5732400B2 (ja)
CN (1) CN102307836B (ja)
AU (1) AU2009326261B2 (ja)
CA (1) CA2747232C (ja)
GB (1) GB0822486D0 (ja)
WO (1) WO2010067069A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2522651B1 (en) * 2011-05-12 2013-11-20 Siegfried AG Process for the purification of 2,6-diisopropyl phenol
US9045684B2 (en) * 2012-07-30 2015-06-02 Jnc Corporation Liquid crystal composition, antioxidant and liquid crystal display device
GB201322905D0 (en) 2013-12-23 2014-02-12 Univ Liverpool Pharmacologically active compounds
EP3189834B1 (en) 2014-09-04 2024-01-17 Haisco Innovative Pharmaceutical PTE. LTD. Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament
WO2017120507A1 (en) * 2016-01-06 2017-07-13 The Board Of Trustees Of The University Of Illinois Novel compounds which activate estrogen receptors and compositions and methods of using the same
US10449198B2 (en) 2016-07-01 2019-10-22 The University Of Liverpool Method for treating pain
CN116554127A (zh) * 2022-01-28 2023-08-08 成都麻沸散医药科技有限公司 哌嗪取代苯酚类衍生物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3498853B2 (ja) 1993-09-27 2004-02-23 小野薬品工業株式会社 ビフェニル誘導体
US6121271A (en) * 1998-05-12 2000-09-19 American Home Products Corporation Naphtho[2,3-B]heteroar-4-yl derivatives
AU3979199A (en) 1998-05-12 1999-11-29 American Home Products Corporation 11-aryl-benzo{b}naphtho{2,3-d}furans and 11-aryl-benzo{b}naphtho{2,3-d}thiophenes useful in the treatment of insulin resistance and hyperglycemia
IL139132A0 (en) 1998-05-12 2001-11-25 American Home Prod Benzothiophenes, benzofurans and indoles useful in the treatment of insulin resistance and hyperglycemia
TWI292316B (en) * 1999-10-11 2008-01-11 Sod Conseils Rech Applic Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
JP2002093609A (ja) * 2000-09-14 2002-03-29 Univ Waseda ラジカル高分子化合物からなる磁性素子
AU2005212834A1 (en) * 2004-02-16 2005-08-25 Laboratorios Del Dr. Esteve S.A. Substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
JP2005234086A (ja) * 2004-02-18 2005-09-02 Konica Minolta Medical & Graphic Inc 光熱写真画像形成材料
WO2006089120A2 (en) * 2005-02-18 2006-08-24 Abraxis Bioscience, Inc Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
CA2632561C (en) * 2005-12-19 2015-01-27 The University Of Liverpool Substituted propofol derivatives as analgesics
CN1907954B (zh) * 2006-08-16 2011-11-23 重庆医科大学医药研究所 麻醉药2,6-二异丙基苯酚的水溶性衍生物及其制备方法

Similar Documents

Publication Publication Date Title
JP2014500861A5 (ja)
JP2013537203A5 (ja)
JP2012511558A5 (ja)
JP2009535462A5 (ja)
JP2006526031A5 (ja)
JP2011518833A5 (ja)
JP2009545527A5 (ja)
JP2012092103A5 (ja)
JP2010511721A5 (ja)
JP2007522220A5 (ja)
JP2010501534A5 (ja)
JP2014508811A5 (ja)
JP2009502743A5 (ja)
JP2005053931A5 (ja)
JP2013518107A5 (ja)
JP2011513410A5 (ja)
JP2011500550A5 (ja)
JP2009501745A5 (ja)
JP2008513510A5 (ja)
JP2007302689A5 (ja)
JP2010501478A5 (ja)
JP2016505614A5 (ja)
JP2010521516A5 (ja)
JP2011529502A5 (ja)
JP2014526533A5 (ja)